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RESEARCH ARTICLE
Intraperitoneal lactate/pyruvate 
ratio and the level of glucose and glycerol 
concentration differ between patients surgically 
treated for upper and lower perforations of the 
gastrointestinal tract: a pilot study
Jonas E. Sabroe1*, Anne R. Axelsen1, Mark B. Ellebæk1, Bjarne Dahler‑Eriksen2 and Niels Qvist1
Abstract 
Background: Secondary peritonitis is a condition associated with high morbidity and mortality. Continuous post‑
operative monitoring of patients to ensure timely intervention to treat complications without delay is important for 
survival and outcome. We aimed to (1) investigate potential differences in postoperative intraperitoneal biomarker 
levels between patients with upper and lower gastrointestinal tract lesion, and (2) compare postoperative biomarker 
levels between complicated and uncomplicated patients.
Methods: We included a total of 15 consecutive patients operated for upper (n = 7) and lower (n = 8) gastrointes‑
tinal tract perforation. We registered postoperative complications during a 30 days follow up‑period. Complications 
were defined as intraabdominal complications, septic shock, and mortality. 5 patients were complicated. A microdialy‑
sis catheter was placed intraperitoneally in each patient. Samples were collected every 4th hour for up to 7 postop‑
erative days. Samples were analysed for concentrations of glucose, lactate, pyruvate and glycerol.
Results: Microdialysis results showed that patients with upper gastrointestinal tract lesions had significantly higher 
levels of postoperative intraperitoneal glucose and glycerol concentrations, as well as lower lactate/pyruvate ratios 
and lactate/glucose ratios. In the group with perforation of the lower gastrointestinal tract, those patients with a com‑
plicated course showed lower levels of postoperative intraperitoneal glucose concentration and glycerol concentra‑
tion and higher lactate/pyruvate ratios and lactate/glucose ratios than those patients with an uncomplicated course.
Conclusion: Patients with upper and lower gastrointestinal tract lesions showed differences in postoperative 
biomarker levels. A difference was also seen between patients with complicated and uncomplicated postoperative 
courses.
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© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Secondary peritonitis (SP), the most commonly encoun-
tered type of peritonitis [1], is defined as an inflammation 
of the peritoneum due to an intraabdominal pathological 
condition [1–3]. The underlying condition in SP is most 
often a rupture of a hollow organ either spontaneously or 
following surgery or trauma [2, 4], and perforation of the 
large bowel is the most frequent [5, 6].
SP is associated with high mortality and morbid-
ity. In-hospital mortality varies between 15% and 47.4% 
depending on the patient material [3, 5, 7, 8]. Morbidity 
includes renal failure, cardiovascular failure, intraabdom-
inal abscesses, and sepsis [4–7].
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The primary treatment is surgical source control. Con-
tinuous postoperative monitoring of patients to ensure 
timely intervention to treat complications without delay 
is important for survival and outcome [9]. Intraperito-
neal microdialysis (IPM) makes it is possible to obtain 
continuous monitoring of the intraabdominal condition 
by measuring several parameters as markers for inflam-
mation or ischaemia. Studies in humans have shown 
promising results of IPM compared to conventional post-
operative monitoring with clinical observations and par-
aclinical examinations in early diagnosis of anastomotic 
leakage [10–13].
To our knowledge no previous published study has 
evaluated IPM as a clinical tool for postoperative moni-
toring of patients treated for secondary or tertiary peri-
tonitis. The present study aimed to assess microdialysis 
in this setting. This pilot study was conducted in order to 
see, if the study could be carried out in a practical and 
safe manner. We also aimed to evaluate the results from 
IPM with continuous measurement of lactate, pyruvate, 
glucose and glycerol concentration in the peritoneal fluid 
in patients operated for peritonitis due to gastrointesti-
nal tract (GI) perforation. The present study should pro-
vide data and information useful in the planning of future 
studies including power calculations. The primary aim 
was to investigate potential differences between patients 
with lower GI lesions (distal to the ligament of Treitz) 
and those with upper GI lesions. We hypothesized that 
a difference between these two groups of patients exists. 
If this is true, one should interpret microdialysis results 
according to the location of the perforation. A secondary 
aim was to determine potential differences in postopera-
tive intraperitoneal biomarker levels between compli-
cated and uncomplicated patients.
Methods
The microdialysis principle
Microdialysis is a minimally invasive technique that 
allows for in vivo sampling of unbound compounds from 
the interstitial space. The microdialysis system includes 
a double-lumen microdialysis catheter, a syringe pump, 
and microvials for collection of dialysates. The cath-
eter is placed in the tissue or cavity of interest, and the 
syringe pump ensures a constant flow of perfusion fluid 
in the catheter. At the tip of the catheter, molecules dif-
fuse across a semipermeable membrane from the inter-
stitial space to the perfusion fluid inside the catheter. The 
transfer of molecules is passive from high to low concen-
trations. In this way, the microdialysis catheter mimics 
a capillary. The perfusion fluid is collected in microvi-
als and analysed bedside, thus providing a dynamic view 
of changes in concentrations of molecular substances 
within the interstitial spaces. It has proven to be a safe 
procedure with a low rate of minor complications and no 
major complications [11, 14].
Biomarkers
Traditionally, glycerol, lactate, pyruvate and glucose are 
the substances that most frequently have been meas-
ured using the microdialysis principle [10, 13, 15–23] 
as commercially available equipment provides bedside 
measurements of these substances. Under anaerobic 
conditions (e.g. due to compromised perfusion of tissue) 
pyruvate is converted to lactate. In cases of low levels of 
oxygen or insufficient energy supply, high levels of lac-
tate and low levels of glucose and pyruvate are observed. 
These changes may be an early indication of postopera-
tive complications. When the body is in a catabolic state 
(e.g. following surgery), cleavage of triglyceride results 
in the release of glycerol [13, 24–26]. Glycerol may also 
derive from the breakdown of phospholipids (the major 
component of cell walls) when the cell is depleted of glu-
cose or oxygen [20]. Therefore, glycerol should increase 
in patients with postoperative complications; however, 
the opposite has also been demonstrated [11, 13], and the 
mechanism behind the increase and decrease in intra-
peritoneal glycerol concentration following surgery is not 
fully understood.
Setting
This prospective observational single-centre study was 
conducted at the surgical department of Odense Uni-
versity Hospital. The study was conducted according to 
the Declaration of Helsinki following approvals from the 
Danish Health and Medicines Authority (EudraCT No.: 
2012-004398-22), the Regional Scientific Ethical Com-
mittees for Southern Denmark (ID: S-20130018), and the 
Danish Data Protection Agency (2008-58-0035).
Patients and procedures
Inclusion criteria included: more than 18  years of age; 
informed written consent obtained from the patient 
or relatives; contamination of two of the four abdomi-
nal quadrants with overt peritonitis. Exclusion criteria 
included known severe renal disease (estimated glomer-
ular filtration rate (eGFR)  <  30  mL/min/1.73  m2) and 
known intolerance to standard antibiotic regimens.
From July 15th 2013 to April 14th 2014, we registered 
35 consecutive patients eligible for the study (Fig.  1). 
From this cohort we excluded 20 patients. 1 patient died 
prior to inclusion. 4 patients did not have peritonitis, and 
1 patient had local peritonitis confined to one abdominal 
quadrant only. 3 were unable to consent and 1 patient 
refused to participate. In 2 cases, we lacked equip-
ment. The attending surgeons did not include 4 patients 
because of various logistic reasons. Microdialysis data 
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was lost from 1 patient, and 1 patient had accidental pre-
term removal of the microdialysis catheter. 2 patients 
were not included for reasons unknown. In total, we 
included 15 evaluable patients.
Comorbidities, including cardiovascular disease 
(CVD), chronic obstructive pulmonary disease (COPD), 
diabetes and active cancer, were registered. CVD was 
defined as hypertension, angina, arrhythmia, claudica-
tion, previous myocardial infarction, previous apoplexy, 
previous transitory cerebral ischaemia, previous cardiac 
bypass operation and/or previous coronary angiography.
It was left to the surgeon’s discretion to choose between 
laparoscopy and laparotomy. All patients received 
intravenous antibiotic prophylaxis with 3  g cefuroxim 
Fig. 1 Flowchart of participant inclusion
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 (Zinacef®, Actavis, Gentofte, Denmark) and 1.5  g met-
ronidazole (Baxter A/S, Allerød, Denmark) either within 
30  min prior to skin incision or when peritonitis was 
diagnosed during surgery. At the end of the surgical 
procedure, a microdialysis catheter was placed into the 
peritoneal cavity by use of a splittable introducer (Flocare 
 Jejunokath®, Nutricia, Erlangen, Germany). The tip of the 
catheter was placed free floating in the most contami-
nated region of the abdomen. The microdialysis catheter 
was fixated to the skin to avoid dislocation. Every patient 
had a central venous line (CVL) inserted. Following sur-
gery, patients were either transferred to an intensive care 
unit (ICU) or recovery ward depending on the clinical 
status of the individual patient.
Microdialysis set‑up
A microdialysis catheter (CMA 65 custom-made micro-
dialysis catheter, M Dialysis AB, Stockholm, Sweden) 
with a cut-off value of 100  kDa, a membrane length of 
30  mm (material: polyethersulfone), and a shaft length 
of 310  mm was used in this study. The catheter was 
perfused continuously with  Voluven® (Fresenius Kabi, 
Island Brygge, Denmark) via a pump (CMA 106 or 107 
microdialysis syringe pump, CMA Microdialysis AB, 
Stockholm, Sweden) with a flow rate of 0.3  µL/min. 
Dialysates were analysed every 4th hour at the bedside 
for the concentrations of lactate, pyruvate, glucose and 
glycerol using an  ISCUSflex microdialysis analyser (M 
Dialysis AB, Stockholm, Sweden). The lactate/pyruvate 
(L/P) ratio and lactate/glucose (L/G) ratio were calcu-
lated. The microdialysis continued for a maximum of 
7 days.
Data collection and management
The American Society of Anesthesiologists (ASA) score 
[27], acute-phase reactants [C-reactive protein (CRP), 
white blood cell (WBC) count], acid–base status, and 
eGFR were obtained prior to surgery. Sequential Organ 
Failure Assessment (SOFA) score was registered on 
postoperative day (POD) 1 [28]. We registered clinical 
events during a 30-day follow-up period (complications 
related to the surgical intervention, re-leakage from the 
GI tract or formation of intraabdominal fistula, intraab-
dominal abscess or empyema, intestinal ischemia, re-
operation, mortality, and septic shock). Septic shock 
was defined as sepsis and continues hypotension (sys-
tolic blood pressure <90 mmHg or mean arterial pres-
sure <70  mmHg or decrease in systolic blood pressure 
>40  mmHg or lactate concentration >4  mmol/L in 
phripheral blood) despite of fluid resuscitation or need 
for inotropic and/or pressor agents. Analyses of the 
dialysate from the microdialysis catheter were com-
pared to the clinical course.
Statistics
Continuous variables are presented as medians with 
interquartile range (IQR 25th, 75th) or range. Medians 
were compared using the Mann–Whitney U test. Data 
analysis was performed using IBM SPSS Statistics 21. A 
two-sided P value of less than 0.05 was considered statis-
tically significant. We present data from POD 1–5 as all 
patients underwent at least 5 days of IPM.
Results
Three patients underwent primary laparoscopy (No. 1, 
2 and 4), and two were converted to open surgery (No. 
1 and 4). The rest of the patients (n  =  12) underwent 
primary laparotomy. Eight patients and seven patients 
had an organ lesion distal (lower) and proximal (upper) 
to the ligament of Treitz, respectively. The group of 
patients with lower GI perforation included three males 
and five females, median age was 60 years (range 49–80), 
and median body mass index (BMI) was 24.7 (range 
22.6–27.5). The group of patients with upper GI perfo-
ration included two males and five females, median age 
was 63.5 years (range 50–79), and median BMI was 22.7 
(range 15.2–27.7). The median microdialysis sampling 
period was 7  days (range 5–7). The median number of 
postoperative days in the ICU was 0 (range 0–7). Baseline 
patient characteristics are presented in Table  1. Seven 
patients were current smokers. Four patients had active 
cancer at inclusion. Eight patients had CVD. One patient 
had diabetes, and one had COPD. Table  2 summarises 
Table 1 Baseline characteristics
CVD cardiovascular disease, COPD chronic obstructive pulmonary disease
Smoking 
status
Ongoing 
cancer
CVD Diabetes COPD
Upper perforation
 Patient 1 Yes – Yes – –
 Patient 2 Yes – Yes – –
 Patient 3 – – Yes – –
 Patient 4 Yes – – – –
 Patient 5 – – Yes – –
 Patient 6 Yes – – – –
 Patient 7 – – – – –
Lower perforation
 Patient 8 Yes – Yes – –
 Patient 9 – Yes – – –
 Patient 10 Yes – Yes – –
 Patient 11 – Yes Yes – –
 Patient 12 Yes Yes – Yes –
 Patient 13 – – – – –
 Patient 14 Yes – Yes – Yes
 Patient 15 – Yes – – –
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the clinical and paraclinical findings at inclusion. The 
median ASA score was 3.5 and 3 for patients with upper 
and lower GI lesion, respectively. The median SOFA 
score on POD 1 was 4.5 and 9 for patients with upper and 
lower GI lesion, respectively. Details regarding surgical 
procedures are provided in Table 3.
Five patients (No. 8, 10, 11, 12 and 14) experienced 
postoperative complications during a 30-day follow-up 
period. All complicated patients had lower GI perfora-
tion. Three patients (No. 8, 10 and 11) developed one or 
more intraabdominal abscesses. One patient (No. 11) was 
re-operated due to a bladder lesion during primary sur-
gery. One patient (No. 12) developed a fistula between 
the bladder and the rectum. One patient (No. 14) died 
due to sepsis and multiple organ failure.
A possible IPM-related complication occurred in one 
patient (No. 8), who developed an intraabdominal empy-
ema around the microdialysis catheter.
Patients with upper GI perforation showed significantly 
higher levels of postoperative intraperitoneal glucose 
concentration from POD 1 and 3 compared to patients 
with lower GI perforation with and without postop-
erative complications, respectively (Fig. 2). The group of 
patients with upper GI perforation showed significantly 
lower levels of postoperative intraperitoneal L/P ratio 
compared to both groups of patients with lower GI per-
foration (Fig. 2). The same applied for the postoperative 
intraperitoneal L/G ratio, although no statistically sig-
nificant difference was found on POD 1 for patients 
with upper GI perforation compared to uncomplicated 
patients with lower GI perforation (Fig. 2). Patients with 
upper GI perforation showed significantly higher levels 
of postoperative intraperitoneal glycerol concentration 
compared to both groups of patients with lower GI per-
foration (Fig. 2).
Reliable statistical analysis of potential differences 
in the postoperative intraperitoneal biomarker levels 
between complicated and uncomplicated patients with 
lower GI perforation was not possible due to the low 
number of patients. However, we observed a trend that 
patients with complications had lower levels of glucose 
concentration and higher levels of glycerol concentration, 
L/P ratio and L/G ratio (Fig. 2).
Discussion
Postoperative IPM showed significant differences 
between patients with upper GI perforation compared 
to patients with lower GI perforation. Moreover, we reg-
istered a trend in the difference between complicated 
and uncomplicated patients with lower GI perfora-
tion. In general, patients with lower GI perforation had 
lower levels of postoperative intraperitoneal glycerol and 
glucose concentration, as well as higher L/P and L/G 
ratios. Uncomplicated patients with lower GI perforation 
Table 2 Clinical and paraclinical findings at inclusion
MAP mean arterial pressure, ASA American Society of Anesthesiologists, CRP C-reactive protein, WBC white blood cell, eGFR estimated glomerular filtration rate, n/a 
data not available, SOFA sequential organ failure assessment, POD 1 postoperative day 1
MAP 
(mmHg)
ASA 
score
pH Lactate 
(mmol/L)
CRP 
(mg/L)
WBC count 
(10E9/L)
eGRF (mL/
min/1.73 m2)
HCO3
− 
(mmol/L)
SOFA score 
POD 1
Upper perforation
 Patient 1 105.7 3 7.44 2.4 37 18.5 82 25.1 n/a
 Patient 2 87.0 n/a 7.39 3.4 <1 12.8 91 16.2 2
 Patient 3 64.3 4 n/a 2.4 115 6.1 60 20.2 6
 Patient 4 68.0 n/a n/a n/a 138 1.2 55 n/a 1
 Patient 5 124 3 7.50 1.3 <1 7.9 58 25.0 1
 Patient 6 105 2 7.41 0.8 2.2 18.7 95 20.4 2
 Patient 7 66.7 4 7.28 1.9 246 17.5 17 17.7 7
 Median 87.0 3 7.41 2.15 37 12.8 60 20.3 2
Lower perforation
 Patient 8 56.0 3 7.34 5.2 295 6.4 41 n/a 15
 Patient 9 87.0 3 n/a n/a 262 5.5 38 n/a 2
 Patient 10 n/a 4 7.45 3.4 1.9 16.6 116 21.8 5
 Patient 11 136.7 2 7.37 2.5 3.5 8.0 71 23.5 8
 Patient 12 102.3 2 7.39 1.7 110 9.4 104 20.1 2
 Patient 13 112.3 2 n/a n/a 30 10.1 66 n/a 3
 Patient 14 49.7 3 7.37 1.3 598 6.2 33 n/a 5
 Patient 15 86.0 3 n/a n/a 202 7.7 71 n/a 3
 Median 87.0 3 7.37 2.5 156 7.85 68.5 21.8 4
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presented higher concentrations of postoperative glucose 
and lower glycerol concentrations, L/P ratios and L/G 
ratios compared to complicated patients with lower GI 
perforation, and this could be a result of either ischaemia 
or inflammation, or a combination of both.
It has previously been shown that patients who develop 
pancreatic fistula following Whipple’s procedure have 
a high concentration of postoperative intraperitoneal 
glycerol [29], which may be due to leakage of pancreatic 
enzymes into the abdominal cavity. This could also be the 
explanation for higher levels of glycerol concentration 
seen in patients with upper GI perforation compared with 
patients with lower GI perforation. We believe that results 
from the present study indicate that IPM has the poten-
tial to become a supplement to physical examination and 
conventional paraclinical tests in monitoring of patients 
treated for SP. However future studies are warranted. The 
results of this study indicates, that future studies should 
distinguish between patients with upper and lower GI 
perforation, and microdialysis measurements from these 
two groups of patients should be interpreted separately.
To our knowledge, only two studies on IPM after 
urgent surgery for intraabdominal conditions have 
been published. Verdant et  al. [14] conducted a study 
in patients undergoing acute laparotomy, and the study 
population included a mixture of patients with bowel 
perforation, primary peritonitis, mesenteric ischaemia, 
haemorrhage, pancreatitis, cholecystitis, bowel obstruc-
tion, and complications to caustic ingestion. In those 
patients who developed complications, a mean L/P ratio 
of 35 was found at POD 1, increasing to approximately 
50 at POD 5. In patients with an uncomplicated course, 
the mean L/P ratio was 18 at POD 1 and remained at a 
steady level for the rest of the study period. In the pre-
sent study, patients with a complicated course (all diag-
nosed with lower GI perforation) had slightly higher 
intraperitoneal L/P ratios on POD 1 to POD 5 compared 
with the complicated patients in the study of Verdant 
et al. An explanation for this may be that not all patients 
with a complicated course in the study of Verdant et al. 
presented with contamination of the abdominal cav-
ity prior to surgery. Patients with upper GI perforation 
from the present study (all uncomplicated) had lower 
postoperative L/P ratios than uncomplicated patients 
in the study of Verdant et al. Conversely, uncomplicated 
patients with lower GI perforation from the present 
study had higher postoperative L/P ratios compared with 
uncomplicated patients in the study of Verdant et  al. 
This could indicate that lower GI perforation causes a 
more severe inflammatory reaction and/or more ischae-
mia within the abdominal cavity compared with upper 
GI perforation.
In a study by Konstantinos et  al. [30], a microdialy-
sis catheter was inserted into the abdominal cavity in 
Table 3 Surgical findings and interventions
Diag. lap. diagnostic laparoscopy, Expl. lap. explorative laparotomy, PDS polydioxanone, VAC vacuum assisted closure
Cause of  
perforation
Exploration  
method
Surgical  
intervention
Type of  
closing
Duration 
of surgery
Irrigation Drainage
Upper perforation
 Patient 1 Ulcer, prepyloric Diag. lap. converted 
to expl. lap.
Suture of ulcer PDS + staples 1 h 20 min Yes –
 Patient 2 Ulcer, duodenal bulb Diag. lap. Suture of ulcer Vicryl 1 h 10 min Yes –
 Patient 3 Ulcer, duodenum Expl. lap. Billroth II resection PDS 1 h 51 min Yes Yes
 Patient 4 Ulcer, prepyloric Diag. lap. converted 
to expl. lap.
Suture of ulcer PDS 1 h 20 min Yes –
 Patient 5 Ulcer, prepyloric Expl. lap. Suture of ulcer PDS 45 min Yes –
 Patient 6 Ulcer, prepyloric Expl. lap. Suture of ulcer PDS 1 h 3 min Yes –
 Patient 7 Ulcer, duodenal bulb Expl. lap. Suture of ulcer PDS n/a Yes –
Lower perforation
 Patient 8 Rectum perforation do 
to coprostasis
Expl. lap. Hartmann’s procedure PDS + staples 2 h 56 min Yes –
 Patient 9 Perforated c. recti Expl. lap. Hartmann’s procedure PDS 2 h 40 min Yes –
 Patient 10 Perforated diverticulitis Expl. lap Hartmann’s procedure PDS n/a Yes –
 Patient 11 Perforated c. recti Expl. lap. Hartmann’s procedure VAC 2 h 40 min Yes –
 Patient 12 Rectal stump blow out Expl. lap. PDS n/a Yes –
 Patient 13 Perforated diverticulitis Expl. lap. Hartmann’s procedure PDS n/a Yes –
 Patient 14 Perforated coecum do 
to ischemia
Exp.lap. Right sided hemicolectomy 
withileostomy
VAC 2 h 5 min Yes –
 Patient 15 Perforated diverticulitis Exp. Lap. Hartmann’s procedure PDS 3 h 9 min Yes –
Page 7 of 9Sabroe et al. BMC Res Notes  (2017) 10:302 
Fig. 2 Microdialysis results. Postoperative intraperitoneal glucose concentration, lactate/pyruvate ratio, lactate/glucose ratio and glycerol con‑
centration for patients with upper and lower gastrointestinal tract lesions (medians, upper and lower quartiles). Patients with a lower perforation 
are stratified into groups with and without complications. The P values in italics refer to the comparison of patients with an upper perforation to 
patients with a lower perforation and no postoperative complications. The other P values refer to the comparison of patients with an upper perfora‑
tion to patients with a lower perforation and with postoperative complications. UP upper perforation postoperative, LPN lower perforation and no 
complications, LPC lower perforation and with complications
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patients admitted to the ICU with an underlying intraab-
dominal condition. Twenty-one patients were included 
in the study, of which 13 patients underwent surgery. 
Nine patients died. Underlying pathological conditions 
included colectomy, acute pancreatitis, gastric haemor-
rhage, acute abdomen, ileus, and multi-trauma. Levels 
of intraperitoneal glucose, glycerol, lactate and pyruvate 
were observed. For each patient, the authors calculated 
the mean L/P ratio during the first 3  days following 
admission to the ICU. The authors proposed a postop-
erative cut-off value of 25.94 for the risk of death. Both 
complicated and uncomplicated patients with lower GI 
perforation in the present study presented with postop-
erative median L/P ratios on POD 1–5 that exceeded the 
proposed cut-off value of Konstantinos et  al. However, 
only one patient died in the present study. The high post-
operative intraperitoneal L/P ratio registered in patients 
with lower GI perforation in the present study is likely 
to be caused by the faecal abdominal contamination of 
these patients.
The study population of the present study was more 
homogeneous than the study population of the two 
referred studies [14, 30]. It should be expected that differ-
ent abdominal pathological conditions lead to different 
results of IPM. We therefore suggest that future studies 
in IPM stratify patients according to underlying abdomi-
nal pathological condition.
Eight patients were not included in the study due to 
lack of equipment, no inclusion of attending surgeons, 
loss of microdialysis data, and preterm removal of the 
microdialysis catheter. Furthermore 2 patients were not 
included for reasons unknown and 3 patients were una-
ble to consent. This shows that use of microdialysis in 
studies of patients undergoing acute surgery is difficult. 
Particularly recruitment of patients is challenging.
Strengths and limitations
The major strength of the present study is that patients 
were included consecutively and stratified to upper 
and lower GI perforation. Nevertheless, some signifi-
cant limitations exist. Inclusion of patients undergoing 
acute surgery for SP is challenging. Obtaining informed 
consent is difficult due to the clinical condition of the 
patient, which may exclude the sickest patients. Only 
one patient died during the postoperative course, which 
indicates a certain selection among the study population. 
Finally, the sample size of the study is small and hetero-
geneous with regard to baseline characteristics. Due to 
the small sample size we did not perform statistical anal-
ysis with stratification of patients according to baseline 
characteristics. So far no definitive conclusion should be 
made, but the results encourage further studies on the 
applicability of IPM in monitoring of patients surgically 
treated for SP.
Conclusion
Patients with upper and lower GI perforation showed 
differences in the results of IPM during the postopera-
tive period. IPM results were also found to differ between 
complicated and uncomplicated patients with lower 
GI perforation. Future studies on IPM are warranted to 
define the clinical implications.
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